胰高血糖素样肽-1
敏化
医学
肠促胰岛素
内分泌学
内科学
激素
受体
机制(生物学)
免疫学
糖尿病
2型糖尿病
认识论
哲学
出处
期刊:International Journal of Anesthesiology and Resuscitation
[Chinese Medical Association]
日期:2018-09-15
卷期号:39 (9): 892-895
标识
DOI:10.3760/cma.j.issn.1673-4378.2018.09.017
摘要
Background
Central sensitization is a main mechanism underlying pain. Incretin is confined to mediate insulinmimetic effects, but recent study indicates that incretin may affect the central sensitization of pain.
Objective
This article reviews the studies about the effects of incretin on central sensitization of spinal cord in pain.
Content
This review summarized physiological characters and receptor localization of incretin. Glucagon like peptide-1 (GLP-1) and its receptor, glucose-dependent insulinotropic polypeptide (GIP) and its receptor influence the neuronal plasticity and the central sensitization of pain. The cross-talk between GLP-1 and GIP signaling pathway is a potential mechanism of the central sensitization underlying pain.
Trend
Central sensitization underlying pain can be induced by incretin signaling system and their cross-talk is an important and novel concept.
Key words:
Glucose-dependent insulinotropic polypeptide; Glucagon like peptide-1; Pain; Neural plasticity
科研通智能强力驱动
Strongly Powered by AbleSci AI